<DOC>
	<DOCNO>NCT00837577</DOCNO>
	<brief_summary>The phase III clinical trial examines efficacy , safety , tolerability addition MK0431/ONO-5435 Japanese patient type 2 diabetes mellitus ( T2DM ) inadequate glycemic control diet/exercise therapy voglibose monotherapy</brief_summary>
	<brief_title>MK0431/ONO-5435 Phase III Clinical Trial -Add-on Voglibose Study Patients With Type 2 Diabetes Mellitus ( MK0431-104 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Voglibose</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<criteria>Japanese Patients With Type 2 Diabetes Mellitus , Who Have Inadequate Glycemic Control On Diet/Exercise Therapy And Voglibose Monotherapy Patients Have A History Of Type 1 Diabetes Mellitus</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>